Variables Influencing Hospital Stay and 10-Year Staying Trending After Anatomical Lung Resection

Gómez-Hernández, María Teresa; Forcada, Clara; Fuentes, Marta; Novoa, Nuria M.; Aranda, José Luis; Rivas, Cristina; Varela, Gonzalo; Jiménez, Marcelo F.

doi:10.1016/j.arbres.2022.09.018

Cited by 1 publication

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Median hospital stay in our study was 5.2 days (interquartile range 4.8 to 6.8 days), similar to María Teresa Gómez-Hernández (overall mean LOS was 5.53±3.82 days). However, Gómez-Hernández's study, when analyzed by period, shows that the LOS gradually decreased, from six days (IQR: two days) between 2011 and 2014 to five days (IQR: two days) from 2015 to 2018 and three days (IQR: two days) during the period from 2019 to 2021 [21]. This shows we need to improve more because more than half of patients stay in hospital for over five days (58.6%).…”

Section: Discussionmentioning

confidence: 95%

Length of Postoperative Hospital Stay and Related Factors After Lobectomy for Lung Cancer: A Pre-enhanced Recovery After Surgery (ERAS) Single Center Assessment

Tat Bang,

Thanh Vy,

Tap

2024

Cureus

View full text Add to dashboard Cite

Background: Lobectomy for lung cancer often presents a lot of potentially severe complications after surgery for patients. Enhanced Recovery After Surgery (ERAS) is a program to improve unexpected events. When implementing ERAS, there needs to be evidence of relevant factors that prolong hospital stays to encourage the participation of medical staff and leaders. This study is to determine the length of hospital stay (LOS) and its related factors after surgery in patients undergoing lobectomy for non-small cell lung cancer.Methods: A descriptive retrospective study was conducted on 99 patients undergoing lobectomy for nonsmall cell lung cancer at University Medical Center Ho Chi Minh City. Data were extracted from a computerized database of patients who were hospitalized for lobectomy in the treatment of non-small cell lung cancer from January 2018 to December 2021. The primary outcome was the postoperative LOS.Results: Median postoperative LOS was 5.2 days (interquartile range 4.8 to 6.8 days). The complication rate was 19.2%, of which Clavien-Dindo II accounted for the highest at 9.1%. The 30-day readmission rate was 13.1%. The median of LOS in the current cigarette smoker's group was 1.9 days higher than the nevercigarette smoker's group and 1.5 days higher than the former cigarette smokers (p<0.001). Tumor-nodesmetastasis (TNM) stage III showed the highest LOS compared to other stages (p=0.029). Open surgery and thoracoscopic conversion to open showed postoperative LOS about two days longer than thoracoscopic surgery (p<0.001). Performing muscle relaxation and early extubation, multimodal analgesia reduced postoperative LOS by 1.6 days (p<0.001), and preoperative physical therapy and early physical therapy at recovery reduced postoperative LOS by 1.3 days (p<0.001). There was a strong positive correlation between the duration of endotracheal retention, duration of thoracic drainage, amount of blood loss, and postoperative LOS (R>0.5, p<0.001). The duration of the Post-Anesthesia Care Unit and fasting time after surgery showed an average positive correlation with postoperative LOS (0.3

show abstract

Section: Discussionmentioning

confidence: 95%